Inflammation and Bronchoconstriction

The pharmacotherapy of asthma is a complex and evolving topic. Asthma triggers may be divided into two categories: “inflammatory” and “bronchoconstrictive”. Therefore asthma pharmacotherapy revolves around the two main areas: reversal or prevention of airway inflammation and reversal or prevention of bronchial smooth muscle constriction, respectively.

Mark as Understood

© Institute of Clinical Science and Technology (ICST) 2020

Support: admin@clinicalscience.org.uk